In pancreatic cancer, LDH-A K5 acetylation triggers CMA-mediated degradation, while reduced acetylation stabilizes LDH-A, enhances glycolysis, and predicts poor prognosis [80]. Here, LDHA is linked to pancreatic neoplasm.